Malignant neoplasms of the oral cavity and oropharynx treated in Brazil: what do the hospital cancer registries reveal?

Carregando...
Imagem de Miniatura
Citações na Scopus
2
Tipo de produção
article
Data de publicação
2022
Título da Revista
ISSN da Revista
Título do Volume
Editora
ASSOC BRASILEIRA OTORRINOLARINGOLOGIA & CIRURGIA CERVICOFACIAL
Citação
BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY, v.88, n.2, p.168-173, 2022
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Introduction: Head and neck cancer has an impact on the global burden of diseases, representing an important cause of morbidity and mortality in Brazil, as well as worldwide. Objective: To learn and describe the clinical, epidemiological and care configuration provided to patients with cancer of the oral cavity and oropharynx recorded in Brazil, diagnosed from 2007 to 2016. Methods: This is a cross-sectional study, carried out using secondary hospital-based data, using the indirect documentation technique. Results: There were 52,799 hospital records of oral cavity cancer and 34,516 cases of oropharyngeal cancer in the assessed period. There was a predominance of male patients, aged 5059 years, mostly Caucasians, and with a low level of schooling. Throughout the period there was a significant reduction in the positive history of alcohol and tobacco consumption, except for alcoholic beverages in oral cavity cancer. Most patients were diagnosed at an advanced stage of the disease (III or IV). Most patients with oral cavity cancer had no evidence of the disease on follow-up, while most patients with oropharyngeal cancer died. The first most frequent treatment offered to patients with oral cavity cancer was surgery, while for patients with oropharyngeal cancer it chemoradiotherapy predominated. Conclusion: Despite the fact that, in general, there was a reduction in the records of patient alcohol and tobacco consumption, the increase in the number of medical consultations, the predominantly late diagnosis and the patients low level of schooling indicate the need for health education, primary prevention and early diagnosis of cancer of the oral cavity and oropharynx.
Palavras-chave
Epidemiology, Head and neck neoplasms, Health services research, Cancer institute, Database
Referências
  1. Al-Hebshi NN., 2019, CURR ORAL HLTH REP, V6, P145
  2. Bergamasco VD, 2008, REV BRAS CIR CABECA, V37, P15
  3. Berthiller J, 2016, INT J EPIDEMIOL, V45, P835, DOI 10.1093/ije/dyv146
  4. Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492
  5. Casati MFM., 2012, REV BRAS CIR CABECA, V41, P186
  6. Cohen EEW, 2016, CA-CANCER J CLIN, V66, P203, DOI 10.3322/caac.21343
  7. Cohen N, 2018, ORAL MAXIL SURG CLIN, V30, P381, DOI 10.1016/j.coms.2018.06.001
  8. Curado MP, 2009, CURR OPIN ONCOL, V21, P194, DOI 10.1097/CCO.0b013e32832a68ca
  9. Dourado Martins Joana, 2014, Rev. salud pública, V16, P786, DOI 10.15446/rsap.v16n5.40083
  10. Instituto Nacional de Cancer Jose alencar Gomes da Silva, 2020, EST 2020 INC CANC BR
  11. Instituto Nacional de Cancer Jose alencar Gomes da Silva, 2010, REG HOSP CANC PLAN G
  12. Instituto Nacional de Cancer Jose Alencar Gomes da Silva, 2019, TAB REG HOSP CANC
  13. Kfouri SA, 2018, REV BRAS EPIDEMIOL
  14. McDermott JD, 2019, CURR TREAT OPTION ON, V20, DOI 10.1007/s11864-019-0650-5
  15. Miller D., 2019, SEER CANC STAT REV 1
  16. Ministerio da Saude (BR), 2019, VIG FAT RISC PROT DO
  17. Ministerio da Saude (BR), 2019, CONS NAC SAUD
  18. Ribeiro KB, 2011, INT J EPIDEMIOL, V40, P489, DOI 10.1093/ije/dyq249
  19. Tarver T, 2012, J CONS HLTH INTERNET, V16, P366, DOI 10.1080/15398285.2012.701177
  20. World Health Organization, 2004, ICD 10 INT CLASSIFIC
  21. Wünsch Filho Victor, 2010, Rev. bras. epidemiol., V13, P175, DOI 10.1590/S1415-790X2010000200001